适应症
干预措施
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- Bayer
- 入组人数
- 5,821
- 主要终点
- Adverse events, Adverse drug reactions, physician's global assessment of tolerability
研究概览
简要总结
- Data are obtained of Emselex in routine treatment of Overactive Bladder. The general objectives are to evaluate the product safety, compatibility, efficacy and patient acceptance.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients who are treated with Emselex for Overactive Bladder
排除标准
- •Exclusion criteria are the contraindications as specified in the German product information
研究组 & 干预措施
Group 1
干预措施: Darifenacin, Emselex (BAY79-4998) (Drug)
结局指标
主要结局
Adverse events, Adverse drug reactions, physician's global assessment of tolerability
时间窗: After 2-3 months of treatment (long-term 6 months)
次要结局
- Incontinence(At end of study)
- Urgency episodes(At end of study)
- Micturitions / nycturitions(At end of study)
- Physician's assessment of improvement/efficacy(At end of study)
- Physician's assessment of patient's satisfaction with therapeutic effect(At end of study)
- Physician's assessment of patient's ability to hold urine(At end of study)
- Dose and treatment duration of Emselex(At end of study)
研究者
相似试验
终止
不适用
ExAblate Treatment of Metastatic Bone Tumors for the Palliation of PainPain Resulting From Bone MetastasesNCT01834937InSightec17
Unknown
不适用
"Brexpiprazole (Rexulti™) Safety and Efficacy Among Filipino Patients (RAISE) - A Post Marketing Surveillance Program"SchizophreniaMajor Depressive DisorderNCT04641780Otsuka Pharmaceutical, Inc., Philippines300
已完成
不适用
Special Drug Use Investigation for Botox® (Botulinum) Spasticity (BOTOX is a Registered Trademark of Allergan, Inc.)MumpsNCT01390922GlaxoSmithKline1,038
已完成
不适用
A Post-Marketing Observational Study of VYXEOS™Acute Myeloid Leukemia With Myelodysplasia-Related ChangesTherapy-Related Acute Myeloid LeukemiaNCT03526926Jazz Pharmaceuticals52
已完成
不适用
Special Drug Use Investigation for VALTREX (Valaciclovir) (Pediatrics Chickenpox)VaricellaNCT01390857GlaxoSmithKline379